PFR-22-2003 11:53 WEiL, GOTSHAia Manoes LLP Mr.

Affidavit of Conard Metcalf I am an attorney and I represent the plaintiffs in the case of Alber v.

II IAIK PBOCCtESS Bends, Coils, Fittings JgJg*Mag Ladish Co.

EFIlod: Sop 10 2007 3:36 Transaction ID 16249542 Cats No.

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS ) BRIAN K.

1 2 IN THE UNITED STATES DISTRICT COURT FOR THE 3 EASTERN DISTRICT OF LOUISIANA _________________________________________________________ 4 JO ANN BISHOP, ET AL, 5 Plaintiffs, 6 vs.

file:///C|/Users/MadeK42/Desktop/DEPOS%20TO%20UPLOAD/Garabrant%20in%20Abex%20trial%20120905s.txt 1 1 IN THE CIRCUIT COURT OF THE ELEVENTH JUDICIAL CIRCUIT 2 IN AND FOR DADE COUNTY, FLORIDA 3 Case No. 04-16237 CA 42 4 5 JOSEPH MALLIA, 6 vs.

782 Occup Environ Med 2000;57:782-785 Mortality from all cancers of asbestos factory workers in east London 1933-80 G Berry, M L Newhouse, J C Wagner Abstract Objective--To give the observed and ex pected deaths due to cancer at all separate sites in asbestos workers in east London, and to analyse these for overall effect and exposure-response trend.

The new England journal of medicine "discovered" in the West.

PharmaLive: Creating Lung Cancer Risk Models For Specific Populations Refines Prediction NEW!

MICHIGAN DIOXIN EXPOSURE STUDY CHANGE IN BACKGROUND SERUM LEVELS WITH THE NEW 2005 TEFS Hedgeman E1, Hong B1, Chen Q2, Knutson K1, Lee S-Y2, Olson K3, Lohr-Ward B3, LaDronka K3, Maier M4, Luksemburg W 4, Lepkowski J3, Gillespie B2, Franzblau A1, Garabrant D1 1Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan 48109 USA; 2Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan 48109 USA; 3Institue for Social Research, University of Michigan, Ann Arbor, Michigan 48109 USA; 4Vista Analytical Laboratories, El Dorado Hills, California 95762 USA Abstract In June of 2005 the World Health Organization met to reevaluate the toxic equivalency factors for the 29 dioxin-like compounds; TEFs for fourteen of the congeners were changed causing an expected 10 25% decrease in calculated TEQ for the general population.

uFi v\.

Autografting Bone Marrow Transplantation (2001) 27, 821828 2001 Nature Publishing Group All rights reserved 02683369/01 $15.00 www.nature.com/bmt Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma A Shimoni1, TL Smith2, A Aleman1, D Weber3, M Dimopoulos3, P Anderlini1, B Andersson1, D Claxton1, NT Ueno1, I Khouri1, M Donato1, M Korbling1, R Alexanian3, R Champlin1 and S Giralt1 1Department of Blood and Bone Marrow Transplantation, 3Department of Lymphoma and Myeloma, and 2Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA Summary: The study was designed to evaluate the efficacy and safety of an intensive, tri-alkylator conditioning regimen, consisting of thiotepa, busulfan and cyclophosphamide (TBC), prior to autologous hematopoietic cell transplantation in patients with multiple myeloma (MM) and to analyze factors associated with outcome.

EVALUATION OF MICRONUCLEI IN THE PERIPHERAL BLOOD OF CD-I MICE EXPOSED TO BENZENE Phase I Study 2000 ppm - 5 Day Evaluation Sponsored by The American Petroleum Institute Conducted by Raymond R.

Occupational Physicians' Attitudes and Practices in Relation to Occupational Cancer Prevention A Qualitative Study in Southeastern France PIERRE VERGER, CLAIRE PARDON, HELENE DUMESNIL, DANIELLE CHARRIER, BENOIT DE LABRUSSE, MARIE-PASCALE LEHUCHER-MICHEL, ALAIN VIAU, SANDRINE ARNAUD, MARC SOUVILLE We conducted a qualitative survey of 20 occupational physicians (OPs) in southeastern France in 2008 to study their attitudes and practices regarding the pre vention of occupational cancers.